Manufacturer
Deciphera Pharmaceuticals
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 4
- Molecules
- 2
- Therapy areas
- 1
Deciphera Pharmaceuticals is a pharmaceutical manufacturer based in United States. MedsAcross lists 4 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Deciphera Pharmaceuticals, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Deciphera Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Qinlock 50 mg tabletOral | Ripretinib | US FDA | Available on request |
| Romvimza 14 mg capsuleOral | Vimseltinib | US FDA | Available on request |
| Romvimza 20 mg capsuleOral | Vimseltinib | US FDA | Available on request |
| Romvimza 30 mg capsuleOral | Vimseltinib | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Deciphera Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.